Access NAMS 2022 Annual Meeting and Menopause 101 Course Content Anytime, Anywhere with OnDemand.

The 2022 NAMS Annual Meeting OnDemand, with the theme NAMS 2022: Menopause Science and Care—An Inclusive Perspective, offered an outstanding lineup of speakers who addressed a wide variety of topics important to those involved in menopause and midlife women’s health. The program included 11 Plenary Symposia, 3 special lectures, and the Opening Symposium (formerly the Pre-Meeting Symposium) Vasomotor Symptoms: What’s New, What Works.

The 2022 Menopause 101 Course OnDemand, titled Guidelines for Clinical Practice, focused on menopause management for the menopause practitioner.

Stay on top of the latest results from the most important clinical trials and exciting updates on menopause-related issues in midlife women’s health from world-renowned speakers. OnDemand is a great option for those who were not  able to attend the in-person meeting. Order OnDemand now and take a deep dive into your specialty. 

NAMS
OnDemand

Non-Members
$1,000

NAMS Members
$700

In-Training
$350

Order Now!

Menopause
101

Non-Members
$250

NAMS Members
$200

In-Training
$100

Order Now!

NAMS
OnDemand

Non-Members
$1,000

NAMS Members
$700

In-Training
$350

Order Now!

Menopause
101

Non-Members
$250

NAMS Members
$200

In-Training
$100

Order Now!

The 2022 NAMS Annual Meeting OnDemand, with the theme NAMS 2022: Menopause Science and Care—An Inclusive Perspective, offers an outstanding lineup of speakers who will address a wide variety of topics important to those involved in menopause and midlife women’s health. The program includes 11 Plenary Symposia, 3 special lectures, and the Opening Symposium (formerly the Pre-Meeting Symposium) Vasomotor Symptoms: What’s New, What Works.

The 2022 Menopause 101 Course OnDemand, titled Guidelines for Clinical Practice, will focus on menopause management for the average practitioner.

Stay on top of the latest results from the most important clinical trials and exciting updates on menopause-related issues in midlife women’s health from world-renowned speakers. OnDemand is great for those who may not be able to attend the in-person meeting. Order OnDemand now and take a deep drive into your specialty. 

NAMS
OnDemand

Non-Members
$1,000

NAMS Members
$700

In-Training
$350

Order Now!

Menopause
101

Non-Members
$250

NAMS Members
$200

In-Training
$100

Order Now!

OnDemand features give you the ultimate control over your educational experience: 

NAMS22_Icon_3F

Revisit sessions you attended or catch anything you missed

NAMS22_Icon_3B

Earn CME credit

NAMS22_Icon_3E
Stay up-to-date with the latest research and news in your field
NAMS22_Icon_3A
Content sortable by schedule, topic, or presenter

Topics included in NAMS OnDemand:

  • Estrogen Over a Lifespan: The Impact on Cardiovascular Disease 
  • Hormone Therapy 
  • Mental Health 
  • Controversies in Genitourinary Syndrome of Menopause 
  • Breast Cancer 
  • Sleep 
  • Bone Health and Prevention and Treatment of Osteoporosis 
  • Intersectionality and Inclusivity in Midlife Women’s Health 
  • Sexual Health 
  • Weight and Obesity 
  •  
  • The Impact of Perimenopause and Menopause on Weight Status: Through the Lens of Equity 
  • Stress and Its Effect on Cardiovascular Health 
  • Barriers Women Face in Academic Medicine 
  • Top Things You Should Know This Year 
  • And much more 
  •  

About NAMS and OnDemand

NAMS has again partnered with Wolters Kluwer to produce and offer the 2022 NAMS Annual Meeting and Menopause 101 Course OnDemand.

The NAMS Annual Meeting is where professionals involved with menopause and midlife women’s health gather for advanced education in order to improve the health and quality of life of all women during midlife and beyond. 

For healthcare professionals at any stage of their career, the 2022 Annual Meeting and Menopause 101 Course provide comprehensive and exciting updates on today’s most relevant issues relating to menopause and midlife women’s health. 

OnDemand features give you the ultimate control over your educational experience: 

NAMS22_Icon_3F

Revisit sessions you attended or catch anything you missed

NAMS22_Icon_3B

Earn CME credit

NAMS22_Icon_3E
Stay up-to-date with the latest research and news in your field
NAMS22_Icon_3A
Content sortable by schedule, topic, or presenter

CME Info

The 2022 NAMS Annual Meeting OnDemand is a digital library with approximately 25 hours of presentations and the 2022 Menopause 101 Course almost 4 hours of presentations. The presentations are from the NAMS Annual Meeting held October 12-15, 2022, in Atlanta, Georgia. Presentations include fully synchronized audio and slides and offer AMA PRA Category 1 Credit(s)™.
Click here for CME Information

How to Access Content

On subsequent visits, you do not need your personalized access link. You can simply  Login in the upper right corner. Enter the username and password you created.

If you have forgotten your On Demand username or password, click Forgot username/password on the log-in page. Enter the email address that you used when you registered your OnDemand access link and we will send your username and instructions on resetting your password. For security reasons, passwords cannot be emailed.

To access OnDemand, you will need the access code that was sent to you from OnDemand.org. If you purchased before the meeting, your access code will be sent during the meeting. If you purchased after that, your access code was sent immediately after purchase.

If you do not receive your receipt by email with the access code, please check your junk mail. If you need your access code resent, please contact [email protected] and provide the email address that was used to purchase On Demand.

Once you click on your access link, you will be prompted to log-in.  If you have purchased a previous year of On Demand, please log-in with your existing username/password or you can register for a new account. You will then have access to your OnDemand sessions.

FAQs

On the home page, you can browse content by the course session, presenter, or use the search box to enter in a title, partial title, topic, presenter name to identify the session you want to view.  

For a session that includes a single full-length video inclusive of all presentations, select the session title or click on the thumbnail image of the video to launch the session content, which will load on a new page.

Some OnDemand sessions are divided into individual videos for each presentation. To view a session and the presentations available in that session, search as described above for the session and either expand the list of presentations to view complete details, or, if viewing the catalog in “grid” view or on your mobile device, select the “Learn More” text to view presentation details. Once you have identified the presentation you want to view, click on the title or thumbnail to launch the video.

Yes, if you have begun watching a presentation, the player will automatically start at the place you stopped regardless of what device you are on.  In other words, if you start watching a presentation on your work computer, you can immediately start playing at the place you stopped watching on your tablet or phone.  To see a list of presentations that you have recently watched, navigate to the My Activity page and see the Recently Viewed category.

You may have up to three places that control the volume.  Within the video window (place your mouse over the video window and there is a volume control on the bottom right), on your computer and on your speakers if you have external speakers.

The presentation videos cannot be downloaded. Presenters typically prefer to not have their presentations be downloadable. You can however download MP3s of the audio only when you are logged into the online version.  No PDF files of the speaker slides are available for download.

Yes, you must be online to watch sessions.

NAMS 2022: Menopause Science and Care—An Inclusive Perspective and the 2022 Menopause 101 Course OnDemand are automatically formatted to play on most mobile devices.

Sessions are available online for one year from the date of the meeting. Content and CME will expire October 12, 2023.  You must Claim CME within the first year of the posting of the CME activity.  

We can only publish presentations with speaker permission, which can change at any time.  We do our best to keep the content list up to date; however printed materials may not reflect the most accurate content listing if a speaker has requested their presentation not be published after the content list was printed.   

You can download individual MP3s by clicking on the MP3 link under the presentation title or video.  

Yes. To claim CME credit, you must first read the CME information that displays when you log-in for the first time.  After you have watched all the sessions, click on the “CME Certificate” link text in the upper right of the OnDemand screen. 

CME credit may be claimed until October 12, 2023.

CME credit is available for physicians and physician assistants.  

[email protected] or (818) 844-3299; Toll Free (800) 501-2303 (U.S.A. only)

The Following Conditions Apply:
  • If CME credit is available and has been claimed, a refund will not be permitted.
  • For products that include physical CD’s, thumb drives or hard drives, these items must be returned to Wolters Kluwer before a refund can be processed.
  • If the original was purchased with an offer for a premium such as a gift card, the premium must be returned, or a partial refund may be granted that excludes the value of the premium.
Refunds will be permitted within 30 days of receiving online or digital access to your product.

Viewing Requirements

Microsoft Windows 

  • Microsoft Windows 10 
  • Microsoft Edge, Mozilla Firefox, or Google Chrome 
  • Broadband Internet connection 

Apple MacOS 

  • Apple MacOS Mojave (version 10.14) and higher 
  • Apple Safari, Mozilla Firefox, or Google Chrome 
  • Broadband Internet connection 

Apple iPadOS 

  • Apple iPadOS 13 and higher 
  • Apple Mobile Safari 
  • Broadband Internet connection 

Apple iOS 

  • Apple iOS 12 and higher 
  • Apple Mobile Safari 
  • Broadband Internet connection 

Android 

  • Android 9 or later 
  • Chrome browser 

Linux 

Mediasite supports on-demand and live presentation playback on Linux. In order to play back Mediasite content we recommend the following: 

Close Menu

The North American Menopause Society (NAMS) 2021 Virtual Annual Meeting 

The 2021 NAMS Annual Meeting will offer approximately 25 hours of presentations. All sessions include fully synchronized audio and slides. 

Program Release Date: September 21, 2021
Program End Date: September 20, 2022 

Accreditation statement
The North American Menopause Society (NAMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Intended Audience
The 2021 NAMS Annual Meeting is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals who treat or counsel women at midlife and beyond.  

Financial Disclosures: 2021 Scientific Program Committee for Menopause 101 Course, Pre-Meeting Symposium, and Annual Meeting 

Carolyn J. Crandall, MD, MS, FACP, CCD, NCMP, Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF, Jewel M. Kling, MD, MPH, NCMP, FACP, Peter F. Schnatz, DO, FACOG, FACP, NCMP, Chrisandra L. Shufelt, MD, MS, FACP, NCMP, Ann Steiner, MD, FACOG, NCMP, report no relevant financial relationships. Monica M. Christmas, MD, NCMP reports: Consultant/Advisory Board: FDA BRUDAC Committee, COMMA Steering Committee; Grant/Research Support: AllianceChicago, Health Choice Network. Brooke Faught, DNP, WHNP-BC, NCMP, FAANP, IF, reports: Consultant/Advisory Board: Bonafide, Trophikos; Speakers’ Bureau: Lupin, TherapeuticsMD. Heather D. Hirsch, MD, MS, NCMP, reports: Podcast Sponsorship Fee: Uberlube, Rosebud Woman, Cliovana. Hadine Joffe, MD, MSc, reports: Consultant/Advisory Board: Eisai, Jazz, NeRRe/KaNDy, Sojournix; Grant/Research Support: Brigham & Women’s Hospital Funds, Merck, NIH, NIA, NIMH, NCI, NeRRe/KaNDy, Pfizer, QUE Oncology, V Foundation. Spouse: Employee: Merck; Arsenal Biosciences and Tango, consulting and equity. Risa Kagan, MD, FACOG, CCD, NCMP, reports: Consultant/Advisory Board: Amgen, Astellas, Cooper Surgical, Lupin, MsMedicine, Pharmavite, TherapeuticsMD, Jazz Pharmaceuticals; Speakers’ Bureau: Cooper Surgical, TherapeuticsMD. Andrew M. Kaunitz, MD, FACOG, NCMP, reports: Consultant/Advisory Board: Merck, Mithra; Grant/Research Support: Medicines360, Mithra. Lisa C. Larkin, MD, FACP, NCMP, IF, reports: Consultant/Advisory Board: Allergan, Pharmavite, Radius, TherapeuticsMD, Speakers’ Bureau: Allergan, Palatin, TherapeuticsMD. Diane T. Pace, PhD, APRN, FNP-BC, NCMP, IF, FAANP, FAAN, reports: Consultant/Advisory Board: Amag, Astellas, Hologic, TherapeuticsMD; Speakers’ Bureau: Amag, TherapeuticsMD; Grant/Research Support: Pfizer. Nanette F. Santoro, MD, reports: Consultant/Advisory Board: Ansh Labs, Astellas, Menogenix, Grant/Research Support: Menogenix. Alison Shea, MD, PhD, FRCSC, NCMP, reports: Grant/Research Support: Pfizer, Speakers’ Bureau: Pfizer, BioSyent; Consultant/Advisory Board: Sprout. Wen Shen, MD, MPH, reports: Stock/Ownership: Astra Zeneca, Akzo Nobel, Bristol Myers Squibb, Hologic, Johnson & Johnson, Merck. James A. Simon, MD, CCD, NCMP, IF, FACOG, reports: Grant/Research Support: AbbVie, Bayer, Endoceutics, GTx, Ipsen, Myovant, ObsEva SA, TherapeuticsMD, Viveve; Consultant/Advisory Board: AbbVie, Amag, Bayer, CEEK, Covance, Dare Bioscience, Duchesnay, Hologic, KaNDy/NeRRe, Madorra, Mitsubishi, Sebela, Shionogi, Sprout, Tanabe Pharma, TherapeuticsMD; Speakers’ Bureau: AbbVie, Amag, Duchesnay, TherapeuticsMD; Stock/Ownership: Sermonix. Claudio N. Soares, MD, PhD, FRCPC, MBA, reports: Consultant/Advisory Board: Lundbeck, Otsuka; Grant/Research Support: Ontario Research Fund, Ontario Brain Institute, AHSC AFP Innovation Fund. Cynthia A. Stuenkel, MD, NCMP, reports: Consultant/Advisory Board: ICON Clinical Research for Mithra. Rebecca C. Thurston, PhD, FABMR, reports: Consultant/Advisory Board: Astellas, Pfizer, Virtue Health.

NAMS Staff 

Carolyn Develen, Mary Nance, Elizabeth Slogar, report no relevant financial relationships.  

Menopause 101 Course: The Best of Clinical Practice 

The North American Menopause Society (NAMS) designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available. 

Learning Objectives 

By participating in this live activity, attendees should be able to 

Acknowledgment of Commercial Support 

This CME activity is supported in part by educational grant funding from  

Bonafide Health 

Pfizer Inc. 

Pharmavite LLC 

TherapeuticsMD 

Financial Disclosures: Faculty and Moderator  

Ekta Kapoor, MBBS, FACP, NCMP, Ann Steiner, MD, FACOG, NCMP, report no relevant financial relationships. Risa Kagan, MD, FACOG, CCD, NCMP, reports: Consultant/Advisory Board: Amgen, Astellas, Cooper Surgical, Lupin, MsMedicine, Pharmavite, TherapeuticsMD, Jazz Pharmaceuticals; Speakers’ Bureau: Cooper Surgical, TherapeuticsMD. Susan Kellogg-Spadt, PhD, CRNP, IF, FCST, CSC, reports: Consultant/Advisory Board: Bonafide, Good Clean Love, Materna. Sharon J. Parish, MD, reports: Consultant/Advisory Board: Dare Bioscience. Alison Shea, MD, PhD, FRCSC, NCMP, reports: Grant/Research Support: Pfizer, Speakers’ Bureau: Pfizer, BioSyent; Consultant/Advisory Board: Sprout. Andrea J. Singer, MD, FACP, CCD, reports: Consultant/Advisory Board: Agnovos, Amgen, Radius Health, UCB; Grant/Research Support: Radius Health; Speakers’s Bureau: Amgen, Radius Health. 

Pre-Meeting Symposium: Cardiometabolic Health in Midlife Women 

The North American Menopause Society (NAMS) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available. 

Learning Objectives 

By participating in this live activity, attendees should be able to 

Financial Disclosures: Faculty and Moderator  

Rachel M. Bond, MD, FACC, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, JoAnn Manson, MD, DrPH, FACP, NCMP, Puja K. Mehta, MD, FACC, FAHA, Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA, Odayme Quesada, MD, MHS, FAHA, Chrisandra L. Shufelt, MD, MS, FACP, NCMP, Adrienne Youdim, MD, FACP, report no relevant financial relationships. Timothy S. Harlan, MD, FACP, CCMS, reports: Stock/Ownership: drgourmet.com website. 

NAMS 2021: The State of Midlife Women’s Health Today 

The North American Menopause Society (NAMS) designates this live activity for a maximum of 21.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 8.75 pharmacotherapeutic hours are also available. 

Learning Objectives 

By participating in this live activity, attendees should be able to 

Acknowledgment of Commercial Support 

This CME activity is supported in part by educational grant funding from 

Bayer Pharmaceuticals—Plenary Symposium 1 

Bonafide Health—Plenary Symposium 8 

Radius Health—Plenary Symposium 4  

Financial Disclosures: Faculty and Moderators 

Gloria A. Bachmann, MD, MMS, Leslie J. Blackhall, MD, MTS, Alison J. Bruce, MB, ChB, Janine Austin Clayton, MD, FARVO, Carolyn J. Crandall, MD, MS, FACP, CCD, NCMP, Chantel Ianthe Cross, MD, Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF, Katherine A. Guthrie, PhD, PI, Laurie S Jeffers, DNP, FNP-BC, NCMP, Cheryl Cox Kinney, MD, FACOG, NCMP, Jewel M. Kling, MD, MPH, NCMP, FACP, Andrea Z. LaCroix, PhD, PI, Robert D. Langer, MD, MPH, Kendell F. Moseley, MD, Stephanie L. Padilla, PhD, Vikki Pedigo, MSN, WHNP-BC, NBC-HWC, Rebecca B. Perkins, MD, MSc, JoAnn V. Pinkerton, MD, NCMP, Michael S. Policar, MD, MPH, Peter F. Schnatz, DO, FACOG, FACP, NCMP, Chrisandra L. Shufelt, MD, MS, FACP, NCMP, report no relevant financial relationships. Fiona Baker, PhD, reports: Consultant/Advisory Board: Lisa Health. Carolyn A. Bernstein, MD, reports: Consultant/Advisory Board: Percept, Neurolytics. Janet S. Carpenter, PhD, RN, FAAN, reports: Consultant/Advisory Board: RoundGlass, University of Wisconsin; Licenses/Fees: Astellas, Sojournix, Kappa Santé. Lisa Astalos Chism, DNP, APRN, NCMP, FAANP, reports: Consultant/Advisory Board: Hologic, Pharmavite; Speakers’ Bureau: Amag, Astellas, JDS Therapeutics; Royalties/Patents: Jones and Bartlett Publishing. Monica M. Christmas, MD, NCMP reports: Consultant/Advisory Board: FDA BRUDAC Committee, COMMA Steering Committee; Grant/Research Support: AllianceChicago, Health Choice Network. Brooke Faught, DNP, WHNP-BC, NCMP, FAANP, IF, reports: Consultant/Advisory Board: Bonafide, Trophikos; Speakers’ Bureau: Lupin, TherapeuticsMD. Shari Goldfarb, MD, reports: Consultant/Advisory Board: Dare Bioscience, MsMedicine, NanOlogy, Procter & Gamble, Sermonix, Spectrum, TherapeuticsMD. Steven R. Goldstein, MD, NCMP, reports: Consultant/Advisory Board: Cook Medical, Cooper Surgical, Myovant, Scynexis; Equipment Loan: GE Ultrasound. Heather D. Hirsch, MD, MS, NCMP, reports: Podcast Sponsorship Fee: Uberlube, Rosebud Woman, Cliovana. Hadine Joffe, MD, MSc, reports: Consultant/Advisory Board: Eisai, Jazz, NeRRe/KaNDy, Sojournix; Grant/Research Support: Brigham & Women’s Hospital Funds, Merck, NIH, NIA, NIMH, NCI, NeRRe/KaNDy, Pfizer, QUE Oncology, V Foundation. Spouse: Employee: Merck; Arsenal Biosciences and Tango, consulting and equity. Sheryl A. Kingsberg, PhD, reports: Consultant/Advisory Board: Astellas, Bayer, Dare Bioscience, Lupin, Materna, Mitsubishi Tanaba, MsMedicine, Ovoca, Palatin, Pfizer, Strategic Science Technologies, TherapeuticsMD; Speakers’ Bureau: Bayer, Pfizer, TherapeuticsMD; Stock/Ownership: Field Trip, Materna, Viveve. Lisa C. Larkin, MD, FACP, NCMP, IF, reports: Consultant/Advisory Board: Allergan, Pharmavite, Radius, TherapeuticsMD, Speakers’ Bureau: Allergan, Palatin, TherapeuticsMD. Stacy Tessler Lindau, MD, FACOG, reports: Patents/Royalties: UpToDate; Stock/Ownership: NowPow. Pauline M. Maki, PhD, reports: Consultant/Advisory Board: Astellas, Bayer, Johnson & Johnson. Diane T. Pace, PhD, APRN, FNP-BC, NCMP, IF, FAANP, FAAN, reports: Consultant/Advisory Board: Amag, Astellas, Hologic, TherapeuticsMD; Speakers’ Bureau: Amag, TherapeuticsMD; Grant/Research Support: Pfizer. Holly J. Pederson, MD, reports: Consultant/Advisory Board: Myriad Genetics. Susan D. Reed, MD, MPH, reports: Grant/Research Support: Bayer, NIH; Royalties/Patents: UpToDate. Neville Sanjana, PhD, reports: Consultant/Advisory Board: Qiagen, Vertex. Marla Shapiro, CM, MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP, reports: Consultant/Advisory Board and Speaker’s Bureau: Amgen, Aspen, Astellas, Bayer, BioSyvent, Duchesnay, GSK, Merck, Mithra, Pfizer, SearchLight, Sprout, Sunovion, TherapeuticsMD. Wen Shen, MD, MPH, reports: Stock/Ownership: Astra Zeneca, Akzo Nobel, Bristol Myers Squibb, Hologic, Johnson & Johnson, Merck. James A. Simon, MD, CCD, NCMP, IF, FACOG, reports: Grant/Research Support: AbbVie, Bayer, Endoceutics, GTx, Ipsen, Myovant, ObsEva SA, TherapeuticsMD, Viveve; Consultant/Advisory Board: AbbVie, Amag, Bayer, CEEK, Covance, Dare Bioscience, Duchesnay, Hologic, KaNDy/NeRRe, Madorra, Mitsubishi, Sebela, Shionogi, Sprout, Tanabe Pharma, TherapeuticsMD; Speakers’ Bureau: AbbVie, Amag, Duchesnay, TherapeuticsMD; Stock/Ownership: Sermonix. Claudio N. Soares, MD, PhD, FRCPC, MBA, reports: Consultant/Advisory Board: Lundbeck, Otsuka; Grant/Research Support: Ontario Research Fund, Ontario Brain Institute, AHSC AFP Innovation Fund. Cynthia A. Stuenkel, MD, NCMP, reports: Consultant/Advisory Board: ICON Clinical Research for Mithra. Rebecca C. Thurston, PhD, FABMR, reports: Consultant/Advisory Board: Astellas, Pfizer, Virtue Health. Kevin Weber, MD, MHA, reports: Grant/Research Support: AbbVie, Amgen, Lundbeck, Lilly.  

Financial Disclosures: Oral Abstract Presenters 

Bart Clarke, MD, Lyndsey DuBose, PhD, Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF, Summer Ghaith, MD and JD Candidate, Karen P. Jakubowski, PhD, Angie S. Lobo, MD, Fahmeeda Murtaza, BSc, Holly N. Thomas, MD, MS, James E. Tisdale, PharmD, Jewel M. Kling, MD, MPH, NCMP, FACP, Meiyuzhen Qi, MPH, Lindsay Shirreff, MD, MSc(HQ), FRCSC, Nancy Fugate Woods, PhD, RN, FAAN, Emily Heydon Wright, MD, Ms. Betia Zeng, report no relevant financial relationships. David F. Archer, MD, reports: Consultant/Advisory Board: Agile Therapeutics, Evestra, Exeltis, InnovaGyn, Lupin, Mithra, OvsEva, TherapeuticsMD; Grants/Research Support: Actavis, Bayer, Endoceutics, Mithra, Myovant, ObsEva, TherapeuticsMD; Stock/Ownership: InnovaGyn, Agile Therapeutics. Diana L. Bitner, MD, NCMP, reports: Stock/Ownership: True Women’s Health. Barbara J. DePree, MD, NCMP, reports: Speakers’ Bureau: Astellas. Mindy E. Goldman, MD, reports: Consultant/Advisory Board: Madorra, Gabbi. Nanette F. Santoro, MD, reports: Consultant/Advisory Board: Ansh Labs, Astellas, Menogenix, Grant/Research Support: Menogenix. James A. Simon, MD, CCD, NCMP, IF, FACOG, reports: Grant/Research Support: AbbVie, Bayer, Endoceutics, GTx, Ipsen, Myovant, ObsEva SA, TherapeuticsMD, Viveve; Consultant/Advisory Board: AbbVie, Amag, Bayer, CEEK, Covance, Dare Bioscience, Duchesnay, Hologic, KaNDy/NeRRe, Madorra, Mitsubishi, Sebela, Shionogi, Sprout, Tanabe Pharma, TherapeuticsMD; Speakers’ Bureau: AbbVie, Amag, Duchesnay, TherapeuticsMD; Stock/Ownership: Sermonix. Rebecca C. Thurston, PhD, FABMR, reports: Consultant/Advisory Board: Astellas, Pfizer, Virtue Health. Wulf H. Utian, MD, PhD, DSc(Med), FRCOG, FACOG, FICS, reports: Consultant/Advisory Board: Pharmavite.   

Financial Disclosures: Abstract Review Committee 

Foluke M. Alli, MD, FAAFP, NCMP, Kathee D. Andrews, BSc, MD, MCFP, NCMP, Danit Ariel, MD, MS, NCMP, Pelin Batur, MD, FACP, NCMP, CCD, Danette Conklin, PhD, Yamnia Cortes, PhD, MPH, FNP-BC, Sybil Crawford, PhD, Carmen Doom, MD, PhD, NCMP, Gary Elkins, PhD, Mary S. Farhi, MD, MPH, FACOG, NCMP, Mary A. Fischer, PhD, WHNP-BC, NCMP, Carolyn J. Gibson, PhD, MPH, Xuezhi (Daniel) Jiang, MD, PhD, FACOG, NCMP, Amy M. Johnson, MD, FACOG, NCMP, Pallavi Khanna, MD, NCMP, Marybeth Lore, MD, NCMP, Dragana Lovre, MD, Mary L. Marnach, MD, NCMP, Lauren B. Messinger, MD, FACOG, NCMP, Anna Camille J. Moreno, DO, NCMP, Sarah Shaffer, DO, NCMP, Holly N. Thomas, MD, MS, report no relevant financial relationships. Andrea J. Singer, MD, FACP, CCD, reports: Consultant/Advisory Board: Agnovos, Amgen, Radius Health, UCB; Grant/Research Support: Radius Health; Speakers’ Bureau: Amgen, Radius Health. 

Method of Participation and CME Certificate/Certificate of Participation
This product includes CME-eligible sessions. Click on the sessions to view. You must be online and logged into the 2021 NAMS Annual Meeting to claim CME credit.  

To receive CME or a Certificate of Participation for this product, you must: 

  1. Purchase the virtual meeting.
  2. View the CME information and session-specific Learning Objectives.
  3. View the CME-eligible sessions of your choosing. You must view all presentations in a session before completing the evaluation for that session.
  4. Complete the Evaluation by clicking the Earn Credit button next to the session name above the presentation viewing window. You must answer all questions on the evaluation. 
  5. Generate and print your CME certificate or Certificate of Participation. 

Note: You must read the CME information, watch all presentations, and complete the evaluation of each session to receive credit. However, you do not have to view an entire session at once or complete an evaluation at the same time. You may complete an evaluation at any time after watching a session. The certificate generated will be cumulative and will list all sessions/evaluations completed.  

Medium or Combination of Media Used
The 2021 NAMS Virtual Annual Meeting is available in the following formats: 

Provider Contact Information
For Customer Support, contact [email protected] or (818) 844-3299; Toll Free: (800) 501-2303 (U.S.A. only).  Support hours of Operation 6:00 am – 7:00 pm PST. 

The North American Menopause Society (NAMS) 

30050 Chagrin Blvd., Suite 120W 

Pepper Pike, OH 44124 

Telephone: 440-442-7550 

Email: [email protected]